Skip to content

NEOGEN: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NEOGEN

BE 0445.922.856
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€3.0m
2023 · €2.9m+€167,312
Equity
€11.7m
2023 · €8.7m+€3.0m
Cash
€48,607
2023 · €64,484-€15,877
Balance sheet total
€15.2m
2023 · €13.1m+€2.1m

Largest movements

2023 to 2024
Assets
  • Receivables within one year +€2.4m

    up €2.4m (+21.2%), from €11.4m to €13.8m

    of which Other amounts receivable: +€2.7m

  • Intangible fixed assets -€312,318

    down €312,318 (-19.3%), from €1.6m to €1.3m

Equity and liabilities
  • Profit (loss) carried forward +€2.9m

    up €2.9m (+69.4%), from -€4.1m to -€1.3m

  • Trade debts -€494,362

    down €494,362 (-59.9%), from €825,691 to €331,329

  • Accrued charges and deferred income -€431,477

    down €431,477 (-11.9%), from €3.6m to €3.2m

Income statement
  • Financial income +€171,234

    up €171,234 (+34.4%), from €497,268 to €668,502

  • Depreciation -€65,268

    down €65,268 (-14.9%), from €437,411 to €372,143

  • Write-downs +€46,201

    up €46,201, from -€44,341 to €1,860

  • Other operating charges +€31,193

    up €31,193 (+3248.3%), from €960 to €32,153

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €2.9m
Gross operating margin -€18,847
Depreciation +€65,268
Write-downs -€46,201
Other operating charges -€31,193
Other operating items +€46,674
Financial income +€171,234
Financial charges -€19,624
Result 2024 €3.0m

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€42,771
Investment -€58,648
Financing €0
Cash 2023 €64,484
Net result for the year +€3.0m
Depreciation +€372,143
Receivables within one year -€2.4m
Trade debts -€494,362
Accrued charges and deferred income -€431,477
Investment in fixed assets (net) -€58,648
Cash 2024 €48,607
Every line side by side 40 lines
Line Code 2023 2024 Change %
Total assets 20/58 €13,101,493 €15,194,094 +€2.1m +16.0%
Fixed assets 21/28 €1,622,119 €1,308,624 -€313,495 -19.3%
Intangible fixed assets 21 €1,616,832 €1,304,514 -€312,318 -19.3%
Tangible fixed assets 22/27 €5,287 €4,110 -€1,177 -22.3%
Plant, machinery and equipment 23 €5,287 €4,110 -€1,177 -22.3%
Current assets 29/58 €11,479,374 €13,885,470 +€2.4m +21.0%
Amounts receivable within one year 40/41 €11,414,890 €13,836,863 +€2.4m +21.2%
Trade receivables 40 €1,082,044 €754,833 -€327,210 -30.2%
Other amounts receivable 41 €10,332,847 €13,082,030 +€2.7m +26.6%
Cash at bank and in hand 54/58 €64,484 €48,607 -€15,877 -24.6%
Total equity and liabilities 10/49 €13,101,493 €15,194,094 +€2.1m +16.0%
Equity 10/15 €8,664,572 €11,683,012 +€3.0m +34.8%
Contributions 10/11 €12,392,600 €12,392,600 = 0.0%
Capital 10 €7,335,798 €7,335,798 = 0.0%
Issued capital 100 €7,335,798 €7,335,798 = 0.0%
Outside capital 11 €5,056,802 €5,056,802 = 0.0%
Share premium 1100/10 €5,056,802 €5,056,802 = 0.0%
Reserves 13 €402,606 €553,529 +€150,922 +37.5%
Non-distributable reserves 130/1 €402,606 €553,529 +€150,922 +37.5%
Legal reserve 130 €402,606 €553,529 +€150,922 +37.5%
Profit (loss) carried forward 14 -€4,130,635 -€1,263,116 +€2.9m +69.4%
Amounts payable 17/49 €4,436,921 €3,511,082 -€925,839 -20.9%
Amounts payable within one year 42/48 €825,691 €331,329 -€494,362 -59.9%
Trade debts 44 €825,691 €331,329 -€494,362 -59.9%
Suppliers 440/4 €825,691 €331,329 -€494,362 -59.9%
Accrued charges and deferred income 492/3 €3,611,230 €3,179,753 -€431,477 -11.9%
Non-recurring operating income 76A - €65,262 +€65,262
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €437,411 €372,143 -€65,268 -14.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€44,341 €1,860 +€46,201
Other operating charges 640/8 €960 €32,153 +€31,193 +3248.3%
Non-recurring operating charges 66A €46,674 - -€46,674
Gross operating margin 9900 €2,798,557 €2,779,710 -€18,847 -0.7%
Operating profit (loss) 9901 €2,357,852 €2,373,553 +€15,702 +0.7%
Financial income 75/76B €497,268 €668,502 +€171,234 +34.4%
Recurring financial income 75 €497,268 €668,502 +€171,234 +34.4%
Financial charges 65/66B €3,992 €23,615 +€19,624 +491.6%
Recurring financial charges 65 €3,992 €23,615 +€19,624 +491.6%
Profit (loss) for the period before taxes 9903 €2,851,128 €3,018,440 +€167,312 +5.9%
Profit (loss) for the period 9904 €2,851,128 €3,018,440 +€167,312 +5.9%
Profit (loss) for the period to be appropriated 9905 €2,851,128 €3,018,440 +€167,312 +5.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.